Nature Biotechnology | Insilico's AI-Driven IPF Candidate Rentosertib Shows Potential for Biological Age Reversal, as Assessed by Six Proteomic Aging Clocks
<p>First-in-Class Evaluation of an AI-Driven Candidate: This is the first de-novo drug designed with generative AI for a de-novo target discovered using AI and Aging Research (AI aging clocks, AI models and Hallmarks of Aging Assessment). First Universal Consensus Across Six...</p>
Read original article ↗
Related Articles
If found guilty, the French billionaire, worth close to €3.2 billion, and the other defendants face up to seven years in
The developers of the Sony PlayStation 3 emulator RPCS3 have told their social media followers that it is now possible t
'This is not a film': Bullet-riddled Ukrainian ambulance displayed by Russian embassy in Lisbon
Totally wrecked, this vehicle, parked for a day outside the Russian embassy in Lisbon, highlights the reality of the war
An extremely fortunate bargain hunter in Kuwait found three Samsung 980 Pro 2TB SSDs slotted inside a $30 PCIe expansion